晨间信号Morning Signal
《新科学家》 第3609期 · 2026年8月22日 · 中文解读

突变噬菌体治疗大肠杆菌感染

Mutant phages treat E. coli infection · Michael Le Page
约 5 分钟Health在小程序里点播,20 到 60 分钟做好
这篇讲什么
一名患有抗生素耐药性大肠杆菌感染的男子在接受携带CRISPR系统的噬菌体病毒治疗后病情有所改善。
原文开头
Health Mutant phages treat E. coli infection CRISPR-armed bacteria-killing viruses may have helped clear an antibiotic-resistant infection Michael Le Page A MAN with a serious infection caused by antibiotic-resistant Escherichia coli has improved after being given bacteria-killing phage viruses armed with DNA- destroying CRISPR systems. The infection developed in the months after the 65-year-old man had a kidney transplant. It led to a large mass growing on his bladder and large open wounds forming on his abdomen. Conventional treatments, including antibiotics, failed to clear the infection, so the man’s doctors in California asked if they could try an experimental phage treatment developed by a Denmark-based company called SNIPR. …
摘自《新科学家》(New Scientist)第3609期 · 2026年8月22日,Michael Le Page。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章